298 related articles for article (PubMed ID: 7004633)
21. Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines.
Biondi A; Roach JA; Schlossman SF; Todd RF
J Immunol; 1984 Jul; 133(1):281-5. PubMed ID: 6373929
[TBL] [Abstract][Full Text] [Related]
22. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.
Schroit AJ; Fidler IJ
Cancer Res; 1982 Jan; 42(1):161-7. PubMed ID: 7053846
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of liposome-incorporation on liver macrophage activating potencies of rough lipopolysaccharide, lipid A, and muramyl dipeptide. Differences in susceptibility to lysosomal enzymes.
Daemen T; Veninga A; Dijkstra J; Scherphof G
J Immunol; 1989 Apr; 142(7):2469-74. PubMed ID: 2926140
[TBL] [Abstract][Full Text] [Related]
24. Tumoricidal properties of mouse macrophages activated with mediators from rat lymphocytes stimulated with concanavalin A.
Fidler IJ; Darnell JH; Budmen MB
Cancer Res; 1976 Oct; 36(10):3608-15. PubMed ID: 953987
[TBL] [Abstract][Full Text] [Related]
25. The capacity of activated murine macrophages for augmented binding of neoplastic cells: analysis of induction by lymphokine containing MAF and kinetics of the reaction.
Marino PA; Adams DO
J Immunol; 1982 Jun; 128(6):2816-23. PubMed ID: 6804569
[TBL] [Abstract][Full Text] [Related]
26. Increased responsiveness to macrophage-activating factor (MAF) after alteration of macrophage membranes.
Piessens WF; Remold HG; David JR
J Immunol; 1977 Jun; 118(6):2078-82. PubMed ID: 325137
[TBL] [Abstract][Full Text] [Related]
27. Differences in the induction of macrophage cytotoxicity by the specific T lymphocyte factor, specific macrophage arming factor (SMAF), and the lymphokine, macrophage activating factor (MAF).
De Groot JW; De Weger RA; Vandebriel RJ; Den Otter W
Immunobiology; 1989 Jun; 179(2-3):131-44. PubMed ID: 2676851
[TBL] [Abstract][Full Text] [Related]
28. T-cell hybridoma production of macrophage activation factor (MAF) I. Separation of MAF from interferon gamma.
Ratliff TL; Thomasson DL; McCool RE; Catalona WJ
J Reticuloendothel Soc; 1982 May; 31(5):393-7. PubMed ID: 6181257
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of lymphokine-induced macrophage microbicidal activity against Leishmania major by liposomes: characterization of the physicochemical requirements for liposome inhibition.
Gilbreath MJ; Hoover DL; Alving CR; Swartz GM; Meltzer MS
J Immunol; 1986 Sep; 137(5):1681-7. PubMed ID: 3745916
[TBL] [Abstract][Full Text] [Related]
30. Rapid decay of tumoricidal activity and loss of responsiveness to lymphokines in inflammatory macrophages.
Poste G; Kirsh R
Cancer Res; 1979 Jul; 39(7 Pt 1):2582-90. PubMed ID: 87267
[TBL] [Abstract][Full Text] [Related]
31. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats.
Kawase I; Komuta K; Namba M; Yokota S; Ogura T; Kishimoto S
Cancer Res; 1986 Mar; 46(3):1047-54. PubMed ID: 3510719
[TBL] [Abstract][Full Text] [Related]
32. [Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice and rats].
Ogura T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):689-96. PubMed ID: 3083782
[TBL] [Abstract][Full Text] [Related]
33. Activation of tumoricidal properties in macrophages by lymphokines encapsulated in liposomes.
Fidler IJ; Fogler WE
Lymphokine Res; 1982; 1(3):73-7. PubMed ID: 6765335
[No Abstract] [Full Text] [Related]
34. Synergistic effect of liposomes and endotoxins on the activation of rat macrophage tumoricidal activity.
Jeannin JF; Reisser D; Lagadec P; Olsson NO; Martin F
Immunobiology; 1985 Sep; 170(3):211-31. PubMed ID: 3840452
[TBL] [Abstract][Full Text] [Related]
35. Production of C3 as a marker of lymphokine-mediated macrophage activation.
Koestler TP; Kirsh R; Kline T; Rieman D; Greig R; Poste G
Cell Immunol; 1984 Aug; 87(1):1-14. PubMed ID: 6378389
[TBL] [Abstract][Full Text] [Related]
36. Alterations in murine host defense functions by adriamycin or liposome-encapsulated adriamycin.
Mace K; Mayhew E; Mihich E; Ehrke MJ
Cancer Res; 1988 Jan; 48(1):130-6. PubMed ID: 3257160
[TBL] [Abstract][Full Text] [Related]
37. Macrophage-activating factors from different T cell clones induce distinct macrophage functions.
Gemsa D; Debatin KM; Kramer W; Kubelka C; Deimann W; Kees U; Krammer PH
J Immunol; 1983 Aug; 131(2):833-44. PubMed ID: 6190940
[TBL] [Abstract][Full Text] [Related]
38. Macrophage activation by a DNA/cationic liposome complex requires endosomal acidification and TLR9-dependent and -independent pathways.
Yasuda K; Ogawa Y; Yamane I; Nishikawa M; Takakura Y
J Leukoc Biol; 2005 Jan; 77(1):71-9. PubMed ID: 15496451
[TBL] [Abstract][Full Text] [Related]
39. [Influences of inflammatory macrophages on the proliferation of mouse tumor cells in vitro].
Sun DM; Hu XZ; Shi W; Zhang YH
Zhonghua Zhong Liu Za Zhi; 1986 Jul; 8(4):247-9. PubMed ID: 3093180
[TBL] [Abstract][Full Text] [Related]
40. Human monocyte-mediated cytotoxicity against herpes simplex virus-infected cells: activation of cytotoxic monocytes by free and liposome-encapsulated lymphokines.
Koff WC; Showalter SD; Chakrabarty MK; Hampar B; Ceccorulli LM; Kleinerman ES
J Leukoc Biol; 1985 Apr; 37(4):461-72. PubMed ID: 3882870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
